N-vinyl-2-pyrrolidone → 1-[3-(2-Piperidin-1-yl-ethyl)-4,5-dihydro-isoxazol-5-yl]-pyrrolidin-2-one

HRID 1882871

반응식

HRID 1882871 반응식
[CH:1]([N:3]1[CH2:7][CH2:6][CH2:5][C:4]1=[O:8])=[CH2:2].[O-]Cl.[Na+].[N:12]1([CH2:18][CH2:19][CH:20]=[N:21][OH:22])[CH2:17][CH2:16][CH2:15][CH2:14][CH2:13]1>C(Cl)(Cl)Cl>[N:12]1([CH2:18][CH2:19][C:20]2[CH2:2][CH:1]([N:3]3[CH2:7][CH2:6][CH2:5][C:4]3=[O:8])[O:22][N:21]=2)[CH2:17][CH2:16][CH2:15][CH2:14][CH2:13]1

참가 물질

5

반응 조건

온도
0 °C

실험 절차

To a solution of 646 μL (1.5 equivalent) of N-vinyl-pyrrolidin-2-one in 5 mL of chloroform, a biphasic solution of 7.4 mL (3.2 equivalents) of 13% Clorax (NaOCl) and a solution of 629.3 mg (4.03 mmol) of 3-piperidin-1-yl-propionaldehyde oxime compound prepared in Example 2 in 5 mL of chloroform were added slowly over 15 minutes with cooling to 0° C. and stirring vigorously. After reacting at room temperature overnight, the reaction mixture was extracted with chloroform three times, washed with a saturated aqueous solution of sodium carbonate twice following water once, dried over sodium sulfate, filtered and then concentrated under reduced pressure. The concentrate was purified by separation with silica gel column chromatography using chloroform/methanol (30:1) as eluent to obtain 477.4 mg (45% yield) of 1-[3-(2-piperidin-1-yl-ethyl)-4,5-dihydro-isoxazol-5-yl]-pyrrolidin-2-one. Subsequently, 1:1 acid addition salt with oxalic acid was obtained from the diethyl ether solution.

후처리

  1. extractionthe reaction mixture was extracted with chloroform three times
  2. washwashed with a saturated aqueous solution of sodium carbonate twice following water once
  3. dry with materialdried over sodium sulfate
  4. filtrationfiltered
  5. concentrationconcentrated under reduced pressure
  6. customThe concentrate was purified by separation with silica gel column chromatography

출처 및 근거

ORD 기록
ord-c215c43c539b429eb0c01714f31ab002
출처 데이터셋
uspto-grants-2004_07
특허 번호
US06759419B2

연결된 노트

불러오는 중…